Avalo Therapeutics (AVTX) Net Long-Term Debt Issued (Repaid) (2014 - 2022)
Avalo Therapeutics (AVTX) reported Non-Current Debt of $10.47 million for Q1 2023, down 22.4% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Net Long-Term Debt Issued (Repaid) (2014 - 2022) Analysis & Trends
At the end of FY2022, Avalo Therapeutics posted Non-Current Debt of $13.49 million, down 58.9% from FY2021.
- Non-Current Debt has a four-year compound annual growth rate of -1.5% (FY2018 to FY2022).
- By year, Non-Current Debt came in at $32.83 million in FY2021 and $14.33 million in FY2018.
- The Q1 2023 figure ranks as the lowest quarterly Non-Current Debt since Q2 2016.
- Per Business Quant data, the three quarters before Q1 2023 came in at $13.49 million (Q4 2022), $16.5 million (Q3 2022) and $18.71 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 14.81 Mn |
| Jun 30, 2022 | -15.00 Mn |
| Sep 30, 2021 | 13.29 Mn |
| Dec 31, 2019 | -183,114.00 |
| Sep 30, 2019 | -24,342.00 |
| Jun 30, 2019 | -24,342.00 |
| Mar 31, 2019 | -24,342.00 |
| Sep 30, 2017 | -606,610.00 |
| Jun 30, 2017 | -892,721.00 |
| Mar 31, 2017 | -874,700.00 |
| Dec 31, 2016 | -854,732.00 |
| Sep 30, 2016 | -836,474.00 |
| Jun 30, 2016 | -819,119.00 |
| Mar 31, 2016 | -803,900.00 |
| Dec 31, 2015 | -787,946.00 |
| Sep 30, 2015 | -770,864.00 |
| Dec 31, 2014 | -2.25 Mn |
API Access
Avalo Therapeutics Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();